Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11901
CALL
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$923M
| $43.1K | ﹤0.01% |
+1,000
| New | +$43.5K |
|
|
11902
PUT
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$923M
| $43.1K | ﹤0.01% |
+1,000
| New | +$43.5K |
|
|
AUTL
11903
CALL
Autolus Therapeutics
AUTL
$572M
| $43.1K | ﹤0.01% |
18,100
-9,100
| -33% | -$21.6K |
|
11904
Rail Vision
RVSN
$11.3M
| $43K | ﹤0.01% |
+352
| New | +$66.4K |
|
|
DESP
11905
PUT
DELISTED
Despegar.com
DESP
| $43K | ﹤0.01% |
6,100
-1,400
| -19% | -$8.6K |
|
|
ARAV
11906
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
| $43K | ﹤0.01% |
34,100
-54,000
| -61% | -$87.6K |
|
11907
CALL
Caribou Biosciences
CRBU
$169M
| $42.9K | ﹤0.01% |
10,100
+4,100
| +68% | +$18.4K |
|
11908
PUT
H.B. Fuller
FUL
$3.38B
| $42.9K | ﹤0.01% |
600
-14,100
| -96% | -$926K |
|
11909
PUT
Liquidity Services
LQDT
$1.36B
| $42.9K | ﹤0.01% |
2,600
+2,100
| +420% | +$30.8K |
|
11910
Coya Therapeutics
COYA
$112M
| $42.9K | ﹤0.01% |
+10,537
| New | +$48.9K |
|
|
WCN
11911
PUT
Waste Connections
WCN
$41.8B
| $42.9K | ﹤0.01% |
300
-13,200
| -98% | -$1.84M |
|
11912
PUT
Smartbird Inc
BIRD
$30.1M
| $42.8K | ﹤0.01% |
1,700
-1,065
| -39% | -$26.6K |
|
11913
CALL
ADMA Biologics
ADMA
$2.12B
| $42.8K | ﹤0.01% |
11,600
-2,900
| -20% | -$10.7K |
|
|
UROY
11914
CALL
Uranium Royalty Corp
UROY
$1.57B
| $42.8K | ﹤0.01% |
21,400
+13,700
| +178% | +$27.3K |
|
11915
CALL
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.55B
| $42.8K | ﹤0.01% |
1,400
-6,500
| -82% | -$199K |
|
11916
CALL
AnaptysBio
ANAB
$1.73B
| $42.7K | ﹤0.01% |
2,100
+1,700
| +425% | +$34.5K |
|
11917
Genworth Financial
GNW
$3.84B
| $42.7K | ﹤0.01% |
8,537
-161,759
| -95% | -$885K |
|
11918
PUT
CTS Corp
CTS
$1.81B
| $42.6K | ﹤0.01% |
1,000
+900
| +900% | +$39.6K |
|
|
SACH
11919
Sachem Capital Corp
SACH
$37.9M
| $42.6K | ﹤0.01% |
+12,204
| New | +$41.2K |
|
11920
National Grid
NGG
$81.5B
| $42.6K | ﹤0.01% |
+671
| New | +$44K |
|
11921
PUT
Phibro Animal Health
PAHC
$1.39B
| $42.5K | ﹤0.01% |
3,100
-800
| -21% | -$11.5K |
|
11922
PUT
Hackett Group
HCKT
$265M
| $42.5K | ﹤0.01% |
1,900
-2,600
| -58% | -$50.9K |
|
11923
CALL
IBEX
IBEX
$480M
| $42.5K | ﹤0.01% |
+2,000
| New | +$42.8K |
|
11924
CALL
NRX Pharmaceuticals
NRXP
$140M
| $42.4K | ﹤0.01% |
8,770
-60
| -0.7% | -$361 |
|
11925
CALL
Fate Therapeutics
FATE
$308M
| $42.4K | ﹤0.01% |
8,900
-12,600
| -59% | -$69.5K |
|
Similar funds
Citadel Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.
- Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
- Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Citadel Advisors opened 1,205 new positions and closed 1,562 in Q2 2023.
- Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.